Tedisamil (KC 8857) is a new specific bradycardic drug: Does it also influence myocardial contractility? Analysis by the conductance (volume) technique in coronary artery disease

This publication has 39 references indexed in Scilit:

• Hemodynamic and antiischemic effects of tedisamil in humans
  Cardiovascular Drugs and Therapy, 1992
• Do Class 1 Antiarrhythmic Drugs Impair Myocardial Contractility? The Class 1A Example of Ajmaline (Conductance Catheter Technique)
  Journal of Cardiovascular Pharmacology, 1990
• Influence of coronary occlusion during PTCA on end-systolic and end-diastolic pressure-volume relations in humans.
  Circulation, 1990
• Electrophysiological profile of KC 8857, a new bradycardic agent
  Journal of Molecular and Cellular Cardiology, 1987
• Cardiovascular profile of KC 8857 in comparison with other cardioactive agents
  Journal of Molecular and Cellular Cardiology, 1987
• KC 8857, a new compound with combined bradycardic and positive inotropic effects
  Journal of Molecular and Cellular Cardiology, 1987
• Assessment of left ventricular end-systolic pressure-volume relations with an impedance catheter and transient inferior vena cava occlusion: Use of this system in the evaluation of the cardiotonic effects of dobutamine, milrinone, posicor and epinephrine
  Journal of the American College of Cardiology, 1986
• Continuous measurement of left ventricular volume in animals and humans by conductance catheter.
  Circulation, 1984
• The metabolic demand and oxygen supply of the heart: Physiologic and clinical considerations
  The American Journal of Cardiology, 1979
• Effects of Heart Rate on Coronary Flow and Cardiac Oxygen Consumption
  American Journal of Physiology-Legacy Content, 1956